FORMA THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2007-01-01
- Employees
- 101
- Market Cap
- -
Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-09-07
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Forma Therapeutics, Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT02543879
- Locations
- 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States
🇺🇸Cedars Sinai, Los Angeles, California, United States
🇺🇸Florida Cancer Specialists, Sarasota, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath